×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
STAA – staar surgical company (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
STAA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
05:23 pm
staa
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. [Yahoo! Finance]
Medium
Report
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. [Yahoo! Finance]
12/17
04:53 pm
staa
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
Medium
Report
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
12/17
01:17 pm
staa
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
Low
Report
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
12/17
11:33 am
staa
STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value [Yahoo! Finance]
Low
Report
STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value [Yahoo! Finance]
12/17
10:55 am
staa
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
Low
Report
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
12/16
02:24 pm
staa
Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory [Yahoo! Finance]
Low
Report
Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory [Yahoo! Finance]
12/16
01:32 pm
staa
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
Low
Report
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
12/16
10:00 am
staa
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction [Yahoo! Finance]
Low
Report
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/17
07:44 pm
staa
Form SCHEDULE 13D/A STAAR SURGICAL CO Filed by: BROADWOOD PARTNERS, L.P.
Medium
Report
Form SCHEDULE 13D/A STAAR SURGICAL CO Filed by: BROADWOOD PARTNERS, L.P.
12/17
05:12 pm
staa
Form DFAN14A STAAR SURGICAL CO Filed by: BROADWOOD PARTNERS, L.P.
Medium
Report
Form DFAN14A STAAR SURGICAL CO Filed by: BROADWOOD PARTNERS, L.P.
12/16
05:00 pm
staa
Form DFAN14A STAAR SURGICAL CO Filed by: BROADWOOD PARTNERS, L.P.
Medium
Report
Form DFAN14A STAAR SURGICAL CO Filed by: BROADWOOD PARTNERS, L.P.
12/16
04:01 pm
staa
Form PX14A6G STAAR SURGICAL CO Filed by: Yunqi Capital Ltd
Medium
Report
Form PX14A6G STAAR SURGICAL CO Filed by: Yunqi Capital Ltd
12/16
06:02 am
staa
Form DEFA14A STAAR SURGICAL CO
Medium
Report
Form DEFA14A STAAR SURGICAL CO
12/12
08:08 pm
staa
Form 4 STAAR SURGICAL CO For: Dec 11 Filed by: SISITSKY NATHANIEL
Low
Report
Form 4 STAAR SURGICAL CO For: Dec 11 Filed by: SISITSKY NATHANIEL
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/31
Form 8-K STAAR SURGICAL CO For: Jul 31
18.7%
10/30 Q3/2019 9/27/2019 EPS 0.120 ZacksConsensus 0.090 ActVsEst 0.030 - Beat 17.4%
1/13 Form 8-K STAAR SURGICAL CO For: Jan 13 9.9%
2/5 STAAR Surgical Announces Strategic Cooperation Agreement with Senshinkai Eye Institute, A Leading Eye Care Chain in Japan 9.5%
5/3 Form 4 STAAR SURGICAL CO For: May 03 Filed by: BROADWOOD CAPITAL INC 8.0%
2/26 Q4/2019 1/3/2020 EPS 0.120 ZacksConsensus 0.030 ActVsEst 0.090 - Beat 7.9%
3/24 Form 4 STAAR SURGICAL CO For: Mar 20 Filed by: Holliday Keith 6.3%
3/26 STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.9%
4/14 STAAR Surgical (NASDAQ: STAA) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. 5.7%
3/10 STAAR Surgical (NASDAQ: STAA) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $46.00 price target on the stock. 5.1%
10/30 Q3/2019 9/27/2019 EPS 0.120 ZacksConsensus 0.090 ActVsEst 0.030 - Beat 17.4%
1/13 Form 8-K STAAR SURGICAL CO For: Jan 13 9.9%
2/5 STAAR Surgical Announces Strategic Cooperation Agreement with Senshinkai Eye Institute, A Leading Eye Care Chain in Japan 9.5%
5/3 Form 4 STAAR SURGICAL CO For: May 03 Filed by: BROADWOOD CAPITAL INC 8.0%
2/26 Q4/2019 1/3/2020 EPS 0.120 ZacksConsensus 0.030 ActVsEst 0.090 - Beat 7.9%
3/24 Form 4 STAAR SURGICAL CO For: Mar 20 Filed by: Holliday Keith 6.3%
3/26 STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.9%
4/14 STAAR Surgical (NASDAQ: STAA) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. 5.7%
3/10 STAAR Surgical (NASDAQ: STAA) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $46.00 price target on the stock. 5.1%
TOP News Decliners
2/4
Form 8-K STAAR SURGICAL CO For: Feb 04
-7.6%
1/23 Form 4 STAAR SURGICAL CO For: Jan 21 Filed by: ANDREWS DEBORAH J -7.0%
7/25 STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -6.0%
3/19 STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.1%
3/23 STAAR Surgical (NASDAQ: STAA) had its price target lowered by analysts at Stephens from $56.00 to $37.00. They now have an "overweight" rating on the stock. -4.0%
8/1 Form 8-K STAAR SURGICAL CO For: Jul 31 -4.0%
9/9 STAAR Surgical Announces EVO ICL Clinical Program for Its 16th Annual Surgical Experts Summit in Paris, France From September 11 – 13, 2019 -3.5%
4/15 STAAR Surgical to Report First Quarter Results on May 6, 2020 -3.4%
2/26 Staar Surgical Co (STAA) Q4 2019 Earnings Call Transcript [The Motley Fool] -2.7%
5/9 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company - STAA -2.6%
1/23 Form 4 STAAR SURGICAL CO For: Jan 21 Filed by: ANDREWS DEBORAH J -7.0%
7/25 STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -6.0%
3/19 STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.1%
3/23 STAAR Surgical (NASDAQ: STAA) had its price target lowered by analysts at Stephens from $56.00 to $37.00. They now have an "overweight" rating on the stock. -4.0%
8/1 Form 8-K STAAR SURGICAL CO For: Jul 31 -4.0%
9/9 STAAR Surgical Announces EVO ICL Clinical Program for Its 16th Annual Surgical Experts Summit in Paris, France From September 11 – 13, 2019 -3.5%
4/15 STAAR Surgical to Report First Quarter Results on May 6, 2020 -3.4%
2/26 Staar Surgical Co (STAA) Q4 2019 Earnings Call Transcript [The Motley Fool] -2.7%
5/9 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company - STAA -2.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: